#32026R0749Commission Implementing Regulation (EU) 2026/749 amending Union authorisation for Evonik’s Hydrogen Peroxide Product Family
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This regulation updates the existing Union authorisation for Evonik’s Hydrogen Peroxide Product Family by implementing various administrative changes requested by Evonik Operations GmbH. The changes include adding and removing trade names, adding and removing product manufacturers, updating names of active substances and manufacturers, and changing a manufacturer's address. The European Chemicals Agency reviewed the notifications and confirmed these are purely administrative under Article 50(3)(a) of the Biocidal Products Regulation, with all safety and efficacy conditions remaining satisfied. The full summary of product characteristics has been replaced in the Annex to provide a consolidated, updated version that also incorporates minor editorial and layout improvements due to a 2024 register format change.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Removal and addition of multiple trade names for the biocidal product family
- Removal and addition of numerous product manufacturers and their manufacturing sites across EU and EEA countries
- Changes to names of active substances and product manufacturers
+ 3 more changes with Pro
Obligations
What this law requires
Evonik Operations GmbH must maintain the Union authorisation EU-0028964-0000 for the Hydrogen Peroxide Product Family in accordance with the updated summary of product characteristics provided in the Annex to Regulation (EU) 2026/749
Evonik Operations GmbH must ensure all trade names, product manufacturers, active substance names, and manufacturer addresses in their product registrations correspond to those listed in the updated Annex to Implementing Regulation (EU) 2023/2183 as amended by this Regulation
Evonik Operations GmbH must submit notifications to the European Chemicals Agency in accordance with Article 11(1) of Implementing Regulation (EU) No 354/2013 for any future administrative changes to the Union authorisation
All product manufacturers listed in the authorisation (Evonik Antwerpen NV, Evonik Operations GmbH, Evonik Peroxid GmbH, Evonik Peroxide Netherlands BV, Brenntag Schweizerhall AG, and Brenntag GmbH) must operate from the manufacturing sites and addresses specified in the updated summary of product characteristics
The biocidal product family must continue to satisfy all conditions of Article 19 of Regulation (EU) No 528/2012 concerning safety and efficacy following implementation of these administrative changes